US Congress to re-open drug import debate
A new bipartisan attempt to authorize the re-importation of prescription drugs into the USA is likely to be launched in the current year, despite its failure in 2007 (Marketletter January 22, 2007). Similar legislative proposals were sponsored then by Senators Byron Dorgan (Democrat, North Dakota) and Olympia Snowe (Republican, Maine) and in the House of Representatives by Rahm Emanuel (Democrat, Illinois) and Jo Ann Emerson (Republican, Missouri).
The plan is to provide a framework for prescription drugs that are approved by the Food and Drug Administration, and manufactured in facilities meeting the agency's safety standards, to be imported via specially licensed pharmacies and wholesalers, mostly Canada-based.
Election campaign promises?
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze